AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Why Did Cardlytics Plunge 18.18% on Earnings Miss?
Generated by AI AgentAinvest Pre-Market Radar
Thursday, Aug 7, 2025 7:02 am ET1min read
Aime SummaryOn August 7, 2025,
experienced a significant drop of 18.18% in pre-market trading, reflecting a notable decline in investor sentiment.Cardlytics reported a net loss of $9.3 million, or $0.18 per diluted share, for the second quarter of 2025. This financial performance was accompanied by a revenue decline of 9% year-over-year, which narrowly missed analyst expectations. The company's earnings per share (EPS) of -$0.13 exceeded analyst expectations of -$0.39, indicating a better-than-expected performance in terms of earnings.
Despite the revenue decline, Cardlytics' EPS performance suggests that the company is managing its costs effectively. The outlook for the third quarter of 2025 is projected to have revenue ranging from $52.2 million to $58.2 million, providing a glimpse into the company's future financial trajectory. This outlook is crucial for investors as it sets expectations for the upcoming quarter and reflects the company's confidence in its ability to navigate current market challenges.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Getty Images (NYSE:GETY) surges 5.51% on renewed investor confidence
Jan.02 2026
Olaplex Holdings (NASDAQ: OLPX) shares plunged 7.59% on mixed analyst outlooks and shifting institutional positioning.
Jan.02 2026
The Real Brokerage shares surge 7.04% on Jan. 2 2026 driven by regulatory tailwinds and restructuring optimism
Jan.02 2026
Vanda Pharmaceuticals shares surged 25.46% on partnership and FDA Breakthrough Therapy Designation.
Jan.02 2026
Vanda Pharmaceuticals shares surge 25.46% on partnership and FDA breakthrough designation
Jan.02 2026
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments

No comments yet